Trading a MLTX straddle lets you take a pure volatility position on MoonLake Immunotherapeutics without committing to a direction. MoonLake Immunotherapeutics's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate MLTX straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on MLTX profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when MoonLake Immunotherapeutics stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the MLTX straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or radiographic axial spondyloarthritis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the MLTX straddle is the cleanest expression of that view. Our scanner prices every MLTX straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a MLTX straddle into a catalyst or short a MLTX straddle to harvest decay, the options straddle setups that matter are all in one place.
